A meta-analysis of case–control studies showed that the rs4684677 polymorphism in the GHRL gene and the rs572169 polymorphism in the GHSR gene confer an increased risk of breast cancer, whereas the rs696217 and rs2075356 polymorphisms in the GHRL gene protect carriers against breast cancer [34]. This evidence concerns the gene GHSR and breast cancer.